These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20184806)

  • 21. Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients.
    Schmitt GJ; Frodl T; Dresel S; la Fougère C; Bottlender R; Koutsouleris N; Hahn K; Möller HJ; Meisenzahl EM
    Eur Arch Psychiatry Clin Neurosci; 2006 Mar; 256(2):115-21. PubMed ID: 16284713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased dopamine transporter availability in male smokers -- a dual isotope SPECT study.
    Yang YK; Yao WJ; Yeh TL; Lee IH; Chen PS; Lu RB; Chiu NT
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):274-9. PubMed ID: 17900774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1.
    Hsiao MC; Lin KJ; Liu CY; Tzen KY; Yen TC
    Schizophr Res; 2003 Dec; 65(1):39-46. PubMed ID: 14623373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine transporter availability in alcohol and opioid dependent subjects - a
    Grover T; Gupta R; Arora G; Bal CS; Ambekar A; Basu Ray S; Vaswani M; Sharma A
    Psychiatry Res Neuroimaging; 2020 Nov; 305():111187. PubMed ID: 32947183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No changes in striatal dopamine transporter in antidepressant-treated patients with major depression.
    Wu CK; Chin Chen K; See Chen P; Chiu NT; Yeh TL; Lee IH; Yang YK
    Int Clin Psychopharmacol; 2013 May; 28(3):141-4. PubMed ID: 23524636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1.
    Schmitt GJ; Meisenzahl EM; Frodl T; La Fougère C; Hahn K; Möller HJ; Dresel S
    J Psychopharmacol; 2005 Sep; 19(5):488-93. PubMed ID: 16166186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of dopamine transporters with technetium-99m TRODAT-1 and single photon emission computed tomography.
    Bao SY; Wu JC; Luo WF; Fang P; Liu ZL; Tang J
    J Neuroimaging; 2000 Oct; 10(4):200-3. PubMed ID: 11147397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal dopamine transporter binding for predicting the development of delayed neuropsychological sequelae in suicide attempters by carbon monoxide poisoning: A SPECT study.
    Yang KC; Ku HL; Wu CL; Wang SJ; Yang CC; Deng JF; Lee MB; Chou YH
    Psychiatry Res; 2011 Dec; 194(3):219-223. PubMed ID: 22044533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Availability of Striatal Dopamine Transporter in Healthy Individuals With and Without a Family History of ADHD.
    Tai YC; Chi MH; Chu CL; Chiu NT; Yao WJ; Chen PS; Yang YK
    J Atten Disord; 2019 May; 23(7):665-670. PubMed ID: 27401239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele.
    Krause J; Dresel SH; Krause KH; La Fougère C; Zill P; Ackenheil M
    World J Biol Psychiatry; 2006; 7(3):152-7. PubMed ID: 16861140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal presynaptic dopaminergic dysfunction in gambling disorder: A
    Pettorruso M; Martinotti G; Cocciolillo F; De Risio L; Cinquino A; Di Nicola M; Camardese G; Migliara G; Moccia L; Conte E; Janiri L; Di Giuda D
    Addict Biol; 2019 Sep; 24(5):1077-1086. PubMed ID: 30226290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SPECT imaging of dopamine transporters with (99m)Tc-TRODAT-1 in major depression and Parkinson's disease.
    Wu H; Lou C; Huang Z; Shi G
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):63-7. PubMed ID: 21304140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower availability of striatal dopamine transporter in generalized anxiety disorder: a preliminary two-ligand SPECT study.
    Lee LT; Tsai HC; Chi MH; Chang WH; Chen KC; Lee IH; Chen PS; Yao WJ; Chiu NT; Yang YK
    Int Clin Psychopharmacol; 2015 May; 30(3):175-8. PubMed ID: 25647452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine transporter regulation during four nights of REM sleep deprivation followed by recovery--an in vivo molecular imaging study in humans.
    Martins RC; Andersen ML; Garbuio SA; Bittencourt LR; Guindalini C; Shih MC; Hoexter MQ; Bressan RA; Castiglioni ML; Tufik S
    Sleep; 2010 Feb; 33(2):243-51. PubMed ID: 20175408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 99mTc-TRODAT-1 imaging of multiple system atrophy.
    Lu CS; Weng YH; Chen MC; Chen RS; Tzen KY; Wey SP; Ting G; Chang HC; Yen TC
    J Nucl Med; 2004 Jan; 45(1):49-55. PubMed ID: 14734673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced striatal dopamine transporters in people with internet addiction disorder.
    Hou H; Jia S; Hu S; Fan R; Sun W; Sun T; Zhang H
    J Biomed Biotechnol; 2012; 2012():854524. PubMed ID: 22505818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between the availability of dopamine transporter and olfactory function in healthy subjects.
    Pak K; Kim K; Lee MJ; Lee JM; Kim BS; Kim SJ; Kim IJ
    Eur Radiol; 2018 Apr; 28(4):1756-1760. PubMed ID: 29164380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.
    Chung SJ; Lee YH; Yoo HS; Sohn YH; Ye BS; Cha J; Lee PH
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1652-1660. PubMed ID: 30980099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow?
    da Silva N; Szobot CM; Anselmi CE; Jackowski AP; Chi SM; Hoexter MQ; Anselmi OE; Pechansky F; Bressan RA; Rohde LA
    Clin Nucl Med; 2011 Aug; 36(8):656-60. PubMed ID: 21716015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.